20
Apr
2021
15:00
BST
15:00
CET
Webinar
The Science of Ultrasound Renal Denervation
-
Views:
7019
-
Likes:
4
Overview
Why use ultrasound for Renal Denervation (RDN)?
The Science of Ultrasound Renal Denervation brings together four experts to introduce ultrasound renal denervation technology. This one-hour educational program walks you through the core concepts and the pre-clinical evidence used to refine the design that led to the ultrasound renal denervation technology.
If you have watched the on-demand video we would be most grateful if you could complete a short survey. To take part please click HERE
Faculty:
Philipp Lurz
Michael Joner
Felix Mahfoud
Andrew Wu
This webinar is supported by
Agenda
Learning Objectives
- Understand the mechanism of action of ultrasound denervation technology
- Learn the scientific rationales behind the design of ultrasound technology for RDN
- Learn the pre-clinical evidence and histopathology of ultrasound renal denervation
- Hear expert discussions and takeaways
Target Audience
- Interventional Cardiologists
- Hypertension Specialists
- Primary Care Physicians
- General Cardiologists
Faculty Biographies
Philipp Lurz
Prof Philipp Lurz is Director of the Department of Cardiology Universitätsmedizin Mainz, Germany. Prior to this, he served as Deputy Head of the Department at Heart Center Leipzig, Germany. Previously, Prof Lurz was a Clinical Research Fellow at Great Ormond Street Hospital for Children NHS Foundation Trust. He completed his education at the University of Leipzig, and is a member of the German Society of Cardiology. Philipp is widely published in leading international peer-reviewed journals.
Michael Joner
Dr Michael Joner MD completed his medical training at the University of Wuerzburg and spent 2004-2006 as a cardiovascular pathology fellow at the CVPath Institute.
After returning to Germany, since 2007 Dr Joner has been Head of the Preclinical Research at the German Heart Centre in Munich, where he also completed his interventional cardiology residency.
Felix Mahfoud
Prof Felix Mahfoud is a Professor of Cardiology at the University of Basel and the Chairman of the Department of Cardiology at University Hospital Basel, Switzerland. He also holds a position as Visiting Professor at Harvard-MIT, Biomedical Engineering in Boston, MA.
Prof Mahfoud is board-certified in internal medicine, cardiology, intensive care medicine, emergency medicine and hypertension. He is Deputy Editor of the European Journal of Heart Failure and is a Councillor on the Board of the European Society of Cardiology (ESC) for 2024-2026. Additionally, he chairs both the ESC Communication Committee and the Scientific Documents Committee of the EAPCI for the 2024-2026 term.
He has published more than 500 publications in peer-reviewed journals and contributed as a wiring committee member to the 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes, the 2018 ESC/ESH Guidelines for the management of arterial hypertension and the 2023 ESH Guidelines for the management of arterial hypertension.
Andrew Wu
Former Vice President, Research & Development, ReCor Medical
Mr Wu has over 20 years of experience in medical device product development. He has worked on devices in the fields of interventional cardiology, electrophysiology, pulmonology, and women’s health, and has taken a number of them from early concept phase through clinical or commercial launch.